Start for free
Start for free
KH

Kitty Hawk Capital

North America, North Carolina, United States, Charlotte

Description

Kitty Hawk Capital has provided venture capital financing to more than 70 private companies since 1980.

Investor Profile

Kitty Hawk Capital has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (17%)
  • Series A (17%)
  • Series E (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Electronics
  • Fintech
  • Information Technology
  • Mobile
  • Professional Networking
  • Wireless
  • Network Security
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kitty Hawk Capital frequently co-invest with?

Franklin Street Partners
Franklin Street Partners
North America, North Carolina, United States, Chapel Hill
Co-Investments: 1
Anthem Capital Management
Anthem Capital Management
North America, Maryland, United States, Baltimore
Co-Investments: 2
Wakefield Group
Wakefield Group
North America, North Carolina, United States, Charlotte
Co-Investments: 2
Dow
Dow
North America, Michigan, United States, Midland
Co-Investments: 1
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Dogwood Equity
Dogwood Equity
North America, North Carolina, United States, Raleigh
Co-Investments: 1
Intersouth Partners
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
AC
Academy Centennial Fund
North America, North Carolina, United States, Durham
Co-Investments: 1
Quaker BioVentures
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Mid-Atlantic Venture Funds
Mid-Atlantic Venture Funds
North America, Pennsylvania, United States, Bethlehem
Co-Investments: 2

What are some of recent deals done by Kitty Hawk Capital?

Synageva BioPharma

Waltham, Massachusetts, United States

Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series EAug 20, 2008
Amount Raised: $17,170,000
Biolex Therapeutics

Pittsboro, North Carolina, United States

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

BiotechnologyHealth CareMedical
Series BSep 1, 2005
Amount Raised: $36,000,000
Biolex Therapeutics

Pittsboro, North Carolina, United States

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

BiotechnologyHealth CareMedical
Series UnknownAug 21, 2003
Amount Raised: $24,400,000
NetOctave

Morrisville, North Carolina, United States

NetOctave develops silicon-based network security solutions.

Network Security
Series BFeb 11, 2002
Amount Raised: $7,800,000
ScoreBoard

Herndon, Virginia, United States

ScoreBoard, a provider of network management solutions for the wireless last mile.

ElectronicsFinTechInformation TechnologyMobileProfessional NetworkingWireless
Series BJul 21, 2000
Amount Raised: $25,000,000
ScoreBoard

Herndon, Virginia, United States

ScoreBoard, a provider of network management solutions for the wireless last mile.

ElectronicsFinTechInformation TechnologyMobileProfessional NetworkingWireless
Series ASep 14, 1999
Amount Raised: $4,200,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator